slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 86,971-87,000
Pages 3,225
Rows per page 30
Component
86,971-87,000 of 96,741
04
The slide uses a circular graphic to emphasize the 'revolution' in autoimmunity.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What IsLoop · Aha Moment1 hit
13
The slide uses a pyramid structure to represent market size by patient population, with larger populations at the base.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · What Could Be1 hit
15
The slide highlights the mechanism of action (pH/Ca2+ switch, no effector function, optimal recycling) and the clinical pipeline status for MMN, delayed graft function, and dermatomyositis.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Before After1 hit
17
Includes a biological mechanism diagram on the left and a clinical trial design timeline/process on the right.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
19
The slide uses a hub-and-spoke style layout to show relationships between entities.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New Bliss1 hit
07
The slide uses a 'Growth Through Innovation' framework to categorize R&D focus areas.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
14
The slide uses a numbered list to outline strategic pillars leading to a specific financial outcome.AstraZeneca | Investor Conference Presentation Deck | 18 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
04
Uses a hierarchical structure to break down the objective into three strategic pillars.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Solution1 hit
06
The slide uses a timeline framework to communicate both past achievements and future R&D milestones.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Roadmap1 hit
09
Includes a quote from Keith Nuechterlein and specific Cohen's d effect size metrics.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
12
The slide uses a standard clinical trial flow diagram to illustrate the study protocol.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
16
The slide uses a line chart to demonstrate the efficacy of different dosages of COMP360 over 12 weeks.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
23
Includes detailed TEAE (Treatment-emergent Adverse Event) breakdown by dose cohort.ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
24
The slide uses topographical brain maps to visualize EEG data changes across three cohorts (Placebo, Low Dose, High Dose).ATAI | Investor Presentation Deck | 33 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
15
The chart illustrates a significant reduction in negative EBITDA margin as revenue scales.Babylon | Investor Conference Presentation Deck | 19 slides · Babylon
Conference presentation Investor relations Beat · Development1 hit
05
The central diagram represents a knowledge graph or network of interconnected biological data points.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Attention1 hit
08
The slide shows a UI screenshot of a 'BenevolentAI' platform. It highlights a 'PPI Edge Details' modal window.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Interest1 hit
12
The slide highlights a 'Triage criteria' panel with sliders for Biological Rationale, Ligandability, Safety, Tissue Expression, and Therapeutic Evidence.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Desire1 hit
13
The slide shows a UI screenshot with a zoomed-in callout highlighting the 'Literature' tab and evidence table.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Desire1 hit
16
The chart uses a segmented bar approach to compare established industry players against BenevolentAI's projected output.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
18
The chart uses a timeline-like structure to show drug development stages from Target ID to Phase II.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
19
The slide uses a two-column layout to contrast the disease burden (left) with the proposed therapeutic solution (right).BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
21
The slide uses a split-column layout to contrast the disease burden/market need (left) with the proposed solution/mechanism (right).BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
22
The slide uses a process diagram to show the experimental workflow (biopsy to culture to measurement) followed by bar charts showing cytokine reduction.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
24
The chart shows a horizontal bar representation of drug development stages. Some programs are marked with AstraZeneca partnership logos and dates.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · Action1 hit
04
The slide uses a process flow diagram to contrast the company's focus on 'Function' against the 'Sequence' and 'Edit' markets.Berkeley Lights | Investor Conference Presentation Deck | 26 slides · Berkeley Lights
Conference presentation Investor relations Beat · Current Reality (Pain)Loop · Aha Moment1 hit
07
Berkeley Lights | Investor Conference Presentation Deck | 26 slidesBerkeley Lights | Investor Conference Presentation Deck | 26 slides · Berkeley Lights
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Golden Circle1 hit
16
The slide uses a bulleted list structure to categorize M&A evaluation criteria into two main pillars: growth and cost structure, plus a leadership capability callout.Berkeley Lights | Investor Conference Presentation Deck | 26 slides · Berkeley Lights
Conference presentation Investor relations Beat · The Bridge1 hit
20
Berkeley Lights | Investor Conference Presentation Deck | 26 slidesBerkeley Lights | Investor Conference Presentation Deck | 26 slides · Berkeley Lights
Conference presentation Investor relations Beat · The Bridge1 hit
07
The slide uses a consistent quarterly trend analysis across four distinct credit risk metrics.Central Pacific Financial | Results Presentation Deck | 15 slides · Central Pacific Financial
Conference presentation Investor relations Beat · KPI OverviewLoop · Mece Breakdown1 hit